article thumbnail

Juno Pharmaceuticals buys Omega Laboratories

Pharmaceutical Technology

It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

Cosmetics 130
article thumbnail

COVID-19 Vaccine News: Reactions, Efficacy, Dosing and More

The Pharma Data

Rare Vaccination Side Effect in People Who Received Cosmetic Facial Fillers. Food and Drug Administration (FDA) noted that there have been a few reports of people who received cosmetic injections to smooth wrinkles or plump lips having unexpected swelling related to the COVID-19 vaccination. Here’s a look.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters

The Pharma Data

Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., Timing and populations for COVID-19 vaccine booster doses in the coming months. Today, the U.S. director of the FDA’s Center for Biologics Evaluation and Research. “Now

article thumbnail

FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID- 19 Vaccines

The Pharma Data

Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of complete submissions of emergency use authorization (EUA) requests in the coming months that have been publicly announced by COVID-19 vaccine manufacturers.

article thumbnail

FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

The Pharma Data

The Fact Sheet for Healthcare Providers Administering Vaccine now reflects the revision of the authorized use of the Janssen COVID-19 Vaccine and includes a warning statement at the beginning of the fact sheet for prominence which summarizes information on the risk for TTS. Today, the U.S.

article thumbnail

FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

The Pharma Data

Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. November 20, 2020 — The U.S. in partnership with BioNTech Manufacturing GmbH.

article thumbnail

FDA Postpones Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age

The Pharma Data

Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age.